![Eric Ende](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Ende
Directeur Général chez
Wellfit Holdings LLC
Profil
Eric J.
Ende is the founder of Wellfit Holdings LLC.
Current positions include Chairman at Matinas BioPharma, Inc. since 2017, Director at Mount Sinai Innovation Partners, Director at Mesa Therapeutics, Inc., President at Ende Consulting Group, Inc. since 2009, and President at Ende Biomedical Consulting Group, Inc. since 2009.
Former roles include Chairman at Matinas BioPharma Holdings, Inc. from 2022 to 2025, Director at Amylin Pharmaceuticals, Inc., Director at Progenics Pharmaceuticals, Inc. from 2019 to 2020, Director at Genzyme Corp.
from 2010 to 2011, Independent Director at Avadel Pharmaceuticals Plc from 2018 to 2026, Director at NeuBase Therapeutics, Inc. from 2022 to 2023, and Research Analyst at Merrill Lynch, Pierce, Fenner & Smith, Inc. Education includes an undergraduate degree from Emory University in 1990, a doctorate from Icahn School of Medicine at Mount Sinai in 1994, and an MBA from The Leonard N Stern School of Business in 1997.
Postes actifs de Eric Ende
| Sociétés | Poste | Début |
|---|---|---|
Ende Consulting Group, Inc. | President | 07/03/2011 |
Mesa Therapeutics, Inc. | Directeur/Membre du Conseil | - |
Wellfit Holdings LLC
 Wellfit Holdings LLC Information Technology ServicesTechnology Services Provides computer programming services | Directeur Général | - |
Ende Biomedical Consulting Group, Inc.
 Ende Biomedical Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biomedical consulting services | President | 01/01/2009 |
Matinas BioPharma, Inc. | Président | - |
Mount Sinai Innovation Partners
 Mount Sinai Innovation Partners Miscellaneous Commercial ServicesCommercial Services Provides real world application and commercialization of discoveries and inventions | Directeur/Membre du Conseil | - |
Anciens postes connus de Eric Ende
| Sociétés | Poste | Fin |
|---|---|---|
| AVADEL PHARMACEUTICALS PLC | Directeur/Membre du Conseil | 12/02/2026 |
| MATINAS BIOPHARMA HOLDINGS, INC. | Président | 14/03/2025 |
| NEUBASE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 12/05/2023 |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Eric Ende
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
58
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/
 Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/ Investment Banks/BrokersFinance Provides brokerage services | Finance |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Matinas BioPharma, Inc. | |
Matinas BioPharma Holdings, Inc.
 Matinas BioPharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Emory University
 Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
 Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ende Consulting Group, Inc. | |
Mesa Therapeutics, Inc. | |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avadel Pharmaceuticals Plc
 Avadel Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Wellfit Holdings LLC
Wellfit Holdings LLC Information Technology ServicesTechnology Services Provides computer programming services | Technology Services |
Ende Biomedical Consulting Group, Inc.
Ende Biomedical Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biomedical consulting services | Commercial Services |
NeuBase Therapeutics, Inc.
 NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders | Health Technology |
Mount Sinai Innovation Partners
Mount Sinai Innovation Partners Miscellaneous Commercial ServicesCommercial Services Provides real world application and commercialization of discoveries and inventions | Commercial Services |
